Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.

Documenti analoghi

• Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
  di: Pedersen, B K, et al.
  Pubblicazione: (1988)
• Interleukin 2 augmentation of natural killer cell activity in homosexual men with acquired immune deficiency syndrome.
  di: Reddy, M M, et al.
  Pubblicazione: (1984)
• Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity.
  di: Takeda, A, et al.
  Pubblicazione: (1987)
• Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.
  di: Manzano, L, et al.
  Pubblicazione: (1992)
• Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome.
  di: Miyasaka, N, et al.
  Pubblicazione: (1986)